Active, Not Recruiting
An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)
NCT06768671
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
- Locations
-
- Clinical Site North Little Rock, Arkansas, United States
- Clinical Site Stanford, California, United States
- Clinical Site Washington D.C., District of Columbia, United States
- Clinical Site Hollywood, Florida, United States